Literature DB >> 31186523

Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis.

Caroline Pearce1,2, Emma Goettke1, Nina Hallowell3, Pauline McCormack4, Frances Flinter5, Christopher McKevitt6,7.   

Abstract

PURPOSE: We sought to assess the readiness of the United Kingdom (UK) National Health Service to implement a Genomic Medicine Service. We conducted a systematic literature review to identify what is known about factors related to the implementation of genomic medicine in routine health care and to draw out the implications for the UK and other settings.
METHODS: Relevant studies were identified in Web of Science and PubMed from their date of inception to April 2018. The review included primary research studies using quantitative, qualitative, or mixed methods, and systematic reviews. A narrative synthesis was conducted.
RESULTS: Fifty-five studies met our inclusion criteria. The majority of studies reviewed were conducted in the United States. We identified four domains: (1) systems, (2) training and workforce needs, (3) professional attitudes and values, and (4) the role of patients and the public.
CONCLUSION: Mainstreaming genomic medicine into routine clinical practice requires actions at each level of the health-care system. Our synthesis emphasized the organizational, social, and cultural implications of reforming practice, highlighting that demonstration of clinical utility and cost-effectiveness, attending to the compatibility of genomic medicine with clinical principles, and involving and engaging patients are key to successful implementation.

Entities:  

Keywords:  clinical genetics; clinical implementation; genomic medicine; personalized care; service delivery

Mesh:

Year:  2019        PMID: 31186523     DOI: 10.1038/s41436-019-0579-x

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  5 in total

1.  Genomic sequencing in oncology: Considerations for integration in routine cancer care.

Authors:  Belinda Rahman; Alastair Lamb; Andrew Protheroe; Ketan Shah; Joyce Solomons; Jonathan Williams; Elizabeth Ormondroyd
Journal:  Eur J Cancer Care (Engl)       Date:  2022-04-05       Impact factor: 2.328

2.  Myocardial ultrastructure can augment genetic testing for sporadic dilated cardiomyopathy with initial heart failure.

Authors:  Tsunenori Saito; Naoko Saito Sato; Kosuke Mozawa; Akiko Adachi; Yoshihiro Sasaki; Kotoka Nakamura; Eiichiro Oka; Toshiaki Otsuka; Eitaro Kodani; Kuniya Asai; Kyoichi Mizuno; Wataru Shimizu; Roberta A Gottlieb
Journal:  ESC Heart Fail       Date:  2021-09-06

3.  Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative Survey.

Authors:  Megan C Roberts; Lisa P Spees; Andrew N Freedman; William M P Klein; Irene Prabhu Das; Eboneé N Butler; Janet S de Moor
Journal:  JCO Precis Oncol       Date:  2021-04-22

4.  A Web Screening on Educational Initiatives to Increase Citizens' Literacy on Genomics and Genetics.

Authors:  Michele Sassano; Giovanna Elisa Calabrò; Stefania Boccia
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599

5.  Mortality in a neonate with molybdenum cofactor deficiency illustrates the need for a comprehensive rapid precision medicine system.

Authors:  Stephen F Kingsmore; Nanda Ramchandar; Kiely James; Anna-Kaisa Niemi; Annette Feigenbaum; Yan Ding; Wendy Benson; Charlotte Hobbs; Shareef Nahas; Shimul Chowdhury; David Dimmock
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.